You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CDDP

Showing 1 - 25 of 457
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Cervical Cancer Trial in Xi'an (Zimberelimab, Albumin-bound Paclitaxel, Cisplatin)

Recruiting
  • Locally Advanced Cervical Cancer
  • Xi'an, Shaanxi, China
    Hongxi Zhao
Sep 20, 2023

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Aug 16, 2023

Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)

Not yet recruiting
  • Neuroendocrine Carcinoma of the Bladder
  • Bladder Cancer
  • (no location specified)
Oct 14, 2023

Myocardial Infarction Trial in Nanjing (Compound Danshen Dropping Pills (CDDP), Placebo)

Recruiting
  • Myocardial Infarction
  • Compound Danshen Dropping Pills (CDDP)
  • Placebo
  • Nanjing, Jiangsu, China
    First Affiliated Hospital of Nanjing Medical University
Aug 9, 2021

Endometrial Cancer Trial in Houston (Paclitaxel, Carboplatin, Dostarlimab)

Not yet recruiting
  • Endometrial Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2023

Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Tokyo (Nivolumab, 5-FU, CDDP)

Recruiting
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • Nivolumab
  • +3 more
  • Tokyo, Japan
    National Cancer Center Hospital
Apr 5, 2022

Hepatoblastoma Trial in Shanghai (Sodium Thiosulfate Injection, Primary surgery resection, mono CDDP-Group A2)

Recruiting
  • Hepatoblastoma
  • Sodium Thiosulfate Injection
  • +10 more
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center
Jul 23, 2022

Head and Neck Squamous Cell Carcinoma Trial (Nab-paclitaxel, Cisplatin, Tislelizumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Aug 23, 2022

Infiltrating Bladder Urothelial Carcinoma Trial in Montpellier (Radiation + cisplatin, Radiation + cisplatin + gemcitabine)

Active, not recruiting
  • Infiltrating Bladder Urothelial Carcinoma
  • Radiation + cisplatin
  • Radiation + cisplatin + gemcitabine
  • Montpellier, France
    CRLC Val d'Aurelle-Paul Lamarque
Dec 20, 2021

Diseases of Oesophagus Stomach and Duodenum Trial in Houston (Dexamethasone, Diphenhydramine, Famotidine)

Active, not recruiting
  • Diseases of Oesophagus Stomach and Duodenum
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 7, 2022

Oropharynx Cancer Trial in Pittsburgh (procedure, other, radiation, drug)

Recruiting
  • Oropharynx Cancer
  • therapeutic conventional surgery
  • +5 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 4, 2022

Medulloblastoma Trial in Memphis (procedure, drug, radiation)

Recruiting
  • Medulloblastoma
  • Surgical resection
  • +11 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Sep 16, 2022

Lung Cancer Trial in Houston (Cisplatin, Amifostine)

Active, not recruiting
  • Lung Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 29, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Chapel Hill, Charleston (biological, drug, radiation)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Pembrolizumab
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 25, 2022

Urothelial Carcinoma, Bladder Cancer Trial in Houston (Abiraterone acetate, Durvalumab, Methotrexate)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Abiraterone acetate
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 2, 2022

NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Avitinib Maleate
  • +13 more
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 3, 2022

Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)

Recruiting
  • Lung Cancer
  • AMG 510
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

Muscle-Invasive Bladder Carcinoma Trial in Roma (Nivolumab, Nab paclitaxel, Cisplatin)

Not yet recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Roma, Italy
    Roberto iacovelli
Jan 10, 2022

Sinonasal Carcinoma Trial (drug, procedure, other)

Not yet recruiting
  • Sinonasal Carcinoma
  • (no location specified)
Dec 9, 2021

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

Recruiting
  • Stage III Ovarian Cancer
  • +6 more
  • Cytoreductive Surgery (CRS)
  • +6 more
  • Baltimore, Maryland
    Mercy Medical Center
Aug 30, 2022

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Multiple Myeloma Trial in Little Rock (myPRS, Induction 1 - MEL-10+CFZ-TD-PACE, First Transplant - MEL-80+CFZ-TD-PACE + PBSC

Terminated
Has Results
  • Multiple Myeloma
  • myPRS
  • +6 more
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
May 28, 2021

Metastatic Pancreatic Carcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Rochester (Cisplatin, Hyperthermic Intraperitoneal

Not yet recruiting
  • Metastatic Pancreatic Carcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Metastatic Bone Sarcoma, Metastatic Malignant Tumor in the Lung, Metastatic Soft Tissue Sarcoma Trial in Buffalo (Cisplatin,

Recruiting
  • Metastatic Bone Sarcoma
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 24, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in Tampa (Cisplatin, Stereotactic Body Radiation Therapy (SBRT))

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Cisplatin
  • Stereotactic Body Radiation Therapy (SBRT)
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Mar 22, 2022